Literature DB >> 15447671

Chagas' disease parasite promotes neuron survival and differentiation through TrkA nerve growth factor receptor.

Marina V Chuenkova1, Mercio PereiraPerrin.   

Abstract

TrkA is a receptor tyrosine kinase activated primarily by nerve growth factor (NGF) to regulate differentiation, survival, and other important functions of neurons. Given the critical role TrkA plays in neural maintenance, it may be that microbial invaders of the nervous system utilize this receptor to reduce tissue damage for maximizing host-parasite equilibrium. Candidate pathogens could be those, like Trypanosoma cruzi, which may produce relatively little brain or nerve damage in long-lasting infections. We show here that T. cruzi, via its neuraminidase, binds TrkA in a NGF-inhibitable manner, induces TrkA autophosphorylation, and, through TrkA-dependent mechanisms, triggers phosphatidylinositol 3-kinase (PI3K)/Akt kinase signaling, cell survival, and neurite outgrowth. Unlike NGF, the neuraminidase does not react with the apoptosis-causing pan-neurotrophin receptor p75NTR. Therefore, these studies identify a novel and unique TrkA ligand in a microbial invader of the nervous system, raising the thus far unsuspected prospect of TrkA underlying clinical progression of an important human infectious disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447671     DOI: 10.1111/j.1471-4159.2004.02724.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.

Authors:  Daniel Aridgides; Ryan Salvador; Mercio PereiraPerrin
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

2.  Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.

Authors:  Marina V Chuenkova; Mercio Pereiraperrin
Journal:  J Neuroparasitology       Date:  2010-07-26

Review 3.  Multigene families in Trypanosoma cruzi and their role in infectivity.

Authors:  Luis Miguel De Pablos; Antonio Osuna
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

4.  Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkC.

Authors:  Craig Weinkauf; Mercio Pereiraperrin
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

5.  Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response.

Authors:  Ryan Salvador; Daniel Aridgides; Mercio PereiraPerrin
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

Review 6.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

7.  Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy.

Authors:  Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

8.  Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cells.

Authors:  Christine A Petersen; Katherine A Krumholz; John Carmen; Anthony P Sinai; Barbara A Burleigh
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  Auto-antibodies to receptor tyrosine kinases TrkA, TrkB and TrkC in patients with chronic Chagas' disease.

Authors:  B Lu; Z Petrola; A O Luquetti; M PereiraPerrin
Journal:  Scand J Immunol       Date:  2008-04-10       Impact factor: 3.487

10.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.